Tag: Lovenox
Fewer Major Bleeds With Once- Versus Twice-Daily Enoxaparin
In propensity analysis, patients on enoxaparin once daily had fewer bleeds, fewer deaths at 15, 30 days
Anticoagulation Appears Safe for Patients With Brain Mets
Treatment does not cause significant increase in incidence of intracranial hemorrhage
Enoxaparin Prevents VTEs in Advanced Pancreatic Cancer
Enoxaparin effective for preventing VTEs with no adverse effect on major bleeding, chemo efficacy
